Related Experiment Video
Updated: Jan 20, 2026

Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
Intravenous Propofol Allows Fast Intubation in Neonates and Young Infants Undergoing Major Surgery
Stefania Sgrò1, Francesco Morini2, Patrizia Bozza1
1Department of Anesthesia and Critical Care, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
Insights
Propofol anesthesia offers a safe and effective method for rapid induction and intubation in neonates and infants. This anesthetic agent significantly reduces intubation time without compromising intubation quality or hemodynamic stability.
Area of Science:
- Anesthesiology and Critical Care
- Pediatric Surgery
- Neonatal Medicine
Background:
- Rapid anesthetic induction and intubation are critical for the safety of surgical neonates and infants.
- Propofol, an anesthetic agent, is known for its rapid onset and recovery characteristics.
- Evaluating propofol's utility in this vulnerable patient population is essential for optimizing anesthetic practice.
Purpose of the Study:
- To assess the safety and efficacy of anesthesia induction using intravenous propofol bolus in neonates and young infants.
- To compare propofol-induced anesthesia with inhaled sevoflurane for anesthetic induction in infants.
- To evaluate the time to successful orotracheal intubation (OTI) and its quality.
Main Methods:
- A retrospective case-control study compared 80 infants (under 6 months) receiving propofol with 80 receiving sevoflurane for general anesthesia.
- Key metrics included time to successful orotracheal intubation (OTI), OTI quality, and hemodynamic parameters (SBP, DBP, PP, HR, SaO2).
- Adverse effects were recorded, and hemodynamic data were collected at baseline, during intubation, and upon recovery.
Main Results:
- The propofol group achieved significantly faster orotracheal intubation (11.5 seconds) compared to the sevoflurane group (360.0 seconds) (p < 0.0001).
- No significant differences were observed in the quality of orotracheal intubation between the propofol and sevoflurane groups.
- Both anesthetic methods demonstrated comparable safety profiles with no significant complications recorded in either group.
Conclusions:
- Intravenous propofol bolus administration is a safe and effective anesthetic technique for induction and intubation in neonates and infants.
- Propofol facilitates rapid anesthetic induction and intubation, crucial for improving patient outcomes in pediatric surgery.
- The use of propofol does not negatively impact intubation quality or cause hemodynamic compromise in this patient population.
Abstract:
Aim of the study: In selected surgical neonates and infants, the rapidity of induction and intubation may represent an important factor for their safety. Propofol is an anesthetic characterized by a rapid onset and fast recovery time that may reduce time of anesthetic induction and improve post-anesthetic outcome. The aim of this study was to evaluate the safety and efficacy of anesthesia induction in full-term neonates and young infants after propofol bolus administration. Methods: A retrospective case-control study including infants below 6 months of age, undergoing general anesthesia between 2011 and 2013, was carried out. Patients that received intravenous propofol bolus to induce anesthesia were compared to patients who received inhaled sevoflurane. Time to reach successful orotracheal intubation (OTI) was measured in seconds. The quality of OTI was defined as "excellent," "good," and "poor," based on established classification and was reported. Hemodynamic parameters as systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), heart rate (HR), and oxygen saturation (SaO2) were collected before OTI (t0), at OTI (t1), and at spontaneous breathing recovery (t2). Main adverse effects were recorded for both groups. Results are median (IQ range) or prevalence; p < 0.05 was considered significant. Results: 160 infants were enrolled in the study, 80 received propofol and 80 inhaled sevoflurane. Major surgery (involving organs in the thoracic, abdominal, or pelvic cavities) was performed in 64 and 54% of patients in the propofol and sevoflurane group, respectively (p = 0.07). Patients in the propofol group showed a shorter time for OTI [11.5 (4.0-65) vs. 360.0 (228.0-720.0) seconds, (p < 0.0001)]. No difference was found in the quality of OTI between the two groups. No significant complications were recorded in either group. Conclusions: Propofol is a safe and effective anesthetic in neonates and infants permitting rapid induction of anesthesia and rapid intubation, without negative impact on the quality of intubation and haemodynamic compromise.
Related Concept Videos
05:17Intravenous Injections in Neonatal Mice
06:40An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
10:30A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
05:39Non-Intubated Video-Assisted Thoracoscopic Surgery
09:47Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
04:04Blind Endotracheal Intubation in Neonatal Rabbits

